Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 2 | 40 | 633 | 482 | 2 |
| Cost of Goods | 132 | 0 | 496 | 66 | 97 |
| Gross Profit | -131 | 40 | 137 | 416 | -96 |
| Operating Expenses | 12,760 | 12,211 | 11,417 | 5,551 | 3,431 |
| Operating Income | -12,759 | -12,171 | -10,785 | -5,069 | -3,429 |
| Interest Expense | 0 | 0 | 0 | 12 | 18 |
| Other Income | 0 | 0 | 0 | 1 | 5 |
| Pre-tax Income | -12,758 | -12,171 | -10,785 | -5,080 | -3,442 |
| Net Income Continuous | -12,758 | -12,171 | -10,785 | -5,080 | -3,442 |
| Net Income Discontinuous | -3,002 | -2,487 | N/A | N/A | N/A |
| Net Income | $-15,760 | $-14,658 | $-10,785 | $-5,080 | $-3,442 |
| EPS Basic Total Ops | -1,495.65 | -1,646.01 | -1,888.87 | -1,106.34 | -1,025.39 |
| EPS Basic Continuous Ops | -1,211.28 | -1,376.18 | -1,879.44 | -1,100.73 | -1,018.73 |
| EPS Basic Discontinuous Ops | -284.37 | -269.84 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -1,495.65 | -1,646.01 | -1,888.87 | -1,106.34 | -1,025.39 |
| EPS Diluted Continuous Ops | -1,211.28 | -1,376.18 | -1,879.44 | -1,100.73 | -1,018.73 |
| EPS Diluted Discontinuous Ops | -284.37 | -269.84 | N/A | N/A | N/A |
| EBITDA(a) | $-12,486 | $-11,691 | $-10,312 | $-4,939 | $-3,414 |